0000899243-19-006209.txt : 20190305
0000899243-19-006209.hdr.sgml : 20190305
20190305181541
ACCESSION NUMBER: 0000899243-19-006209
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190301
FILED AS OF DATE: 20190305
DATE AS OF CHANGE: 20190305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Campbell Paul
CENTRAL INDEX KEY: 0001657568
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 333-199861
FILM NUMBER: 19660224
MAIL ADDRESS:
STREET 1: BUILDING 4, TRIDENT PLACE
STREET 2: MOSQUITO WAY
CITY: HATFIELD, HERTFORDSHIRE
STATE: X0
ZIP: AL10 9UL
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mylan N.V.
CENTRAL INDEX KEY: 0001623613
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981189497
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
CITY: HATFIELD, HERTFORDSHIRE
STATE: X0
ZIP: AL10 9UL
BUSINESS PHONE: 44 0 1707 853 000
MAIL ADDRESS:
STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
CITY: HATFIELD, HERTFORDSHIRE
STATE: X0
ZIP: AL10 9UL
FORMER COMPANY:
FORMER CONFORMED NAME: New Moon B.V.
DATE OF NAME CHANGE: 20141028
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-01
0
0001623613
Mylan N.V.
MYL
0001657568
Campbell Paul
BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
HATFIELD, HERTFORDSHIRE
X0
AL10 9UL
UNITED KINGDOM
0
1
0
0
See Remarks
Ordinary Shares
2019-03-02
4
M
0
1980
0.00
A
24540
D
Ordinary Shares
2019-03-02
4
F
0
877
27.45
D
23663
D
Ordinary Shares
2019-03-02
4
M
0
167
0.00
A
437
I
By Spouse
Ordinary Shares
2019-03-02
4
F
0
57
27.45
D
380
I
By Spouse
Ordinary Shares
2019-03-03
4
M
0
830
0.00
A
24493
D
Ordinary Shares
2019-03-03
4
F
0
356
27.45
D
24137
D
Ordinary Shares
2019-03-03
4
M
0
219
0.00
A
599
I
By Spouse
Ordinary Shares
2019-03-03
4
F
0
75
27.45
D
524
I
By Spouse
Ordinary Shares (pursuant to existing trading plan)
2019-03-04
4
X
0
11533
12.15
A
35670
D
Ordinary Shares (pursuant to existing trading plan)
2019-03-04
4
S
0
11533
27.4987
D
24137
D
Ordinary Shares
2019-03-05
5
G
0
E
524
0.00
D
0
I
By Spouse
Ordinary Shares
2019-03-05
5
G
0
E
524
0.00
A
24661
D
Ordinary Shares
318
I
By 401(k) Plan
Employee Stock Option - Right to Buy
27.45
2019-03-01
4
A
0
7398
0.00
A
2029-03-01
Ordinary Shares
7398
7398
D
Employee Stock Option - Right to Buy
27.45
2019-03-01
4
A
0
460
0.00
A
2029-03-01
Ordinary Shares
460
460
I
By Spouse
Restricted Stock Units
0.00
2019-03-01
4
A
0
12387
0.00
A
Ordinary Shares
12387
12387
D
Restricted Stock Units
0.00
2019-03-01
4
A
0
1154
0.00
A
Ordinary Shares
1154
1154
I
By Spouse
Restricted Stock Units
0.00
2019-03-02
4
M
0
1980
0.00
D
Ordinary Shares
1980
3960
D
Restricted Stock Units
0.00
2019-03-02
4
M
0
167
0.00
D
Ordinary Shares
167
334
I
By Spouse
Restricted Stock Units
0.00
2019-03-03
4
M
0
830
0.00
D
Ordinary Shares
830
830
D
Restricted Stock Units
0.00
2019-03-03
4
M
0
219
0.00
D
Ordinary Shares
219
220
I
By Spouse
Employee Stock Option - Right to Buy
12.15
2019-03-04
4
X
0
11533
0.00
D
Ordinary Shares
11533
0
D
Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2018.
Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 3, 2017.
The exercise of stock options and sale of ordinary shares were executed pursuant to a 10b5-1 trading plan executed on March 5, 2018.
Represents the acquisition of Mylan ordinary shares upon exercise of stock options granted on March 5, 2009.
Represents the weighted average price of the reporting person's disposition of 11,533 ordinary shares in transactions ranging from $27.37 to $27.59. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.
This transaction involved a gift of securities by the reporting person's spouse to the reporting person on March 5, 2019.
These options vest in three equal annual installments beginning on March 2, 2020 and expire on March 1, 2029.
154 of the options will vest on March 2, 2020, and 153 will vest on each of March 2, 2021 and March 2, 2022. The options expire on March 1, 2029.
Each RSU represents the right to receive one ordinary share of Mylan N.V. The RSUs vest in three equal annual installments beginning on March 2, 2020.
Each RSU represents the right to receive one ordinary share of Mylan N.V. 385 of the RSUs will vest on March 2, 2020, 384 will vest on March 2, 2021, and 385 will vest on March 2, 2022.
Each RSU represents the right to receive one ordinary share of Mylan N.V. One-third of the RSUs granted on March 2, 2018 vested on March 2, 2019 and the remainder of this award will vest equally on March 2, 2020 and March 2, 2021.
Each RSU represents the right to receive one ordinary share of Mylan N.V. 831 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 830 vested on March 3, 2019, and 830 will vest on March 3, 2020.
Each RSU represents the right to receive one ordinary share of Mylan N.V. 220 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 219 vested on March 3, 2019, and 220 will vest on March 3, 2020.
The grant, of which these options were a part, vested in three equal annual installments beginning on March 5, 2010.
Senior Vice President, Chief Accounting Officer & Corporate Controller
/s/ Kevin Macikowski, by power of attorney
2019-03-05